Scott Bowden

5.9k total citations · 1 hit paper
89 papers, 4.3k citations indexed

About

Scott Bowden is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Scott Bowden has authored 89 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Epidemiology, 74 papers in Hepatology and 26 papers in Infectious Diseases. Recurrent topics in Scott Bowden's work include Hepatitis B Virus Studies (72 papers), Hepatitis C virus research (68 papers) and Liver Disease Diagnosis and Treatment (32 papers). Scott Bowden is often cited by papers focused on Hepatitis B Virus Studies (72 papers), Hepatitis C virus research (68 papers) and Liver Disease Diagnosis and Treatment (32 papers). Scott Bowden collaborates with scholars based in Australia, United States and China. Scott Bowden's co-authors include Stephen Locarnini, George Lau, Stephen Locarnini, Sharon R. Lewin, William E. Delaney, Paul Desmond, Zachary Goodman, Christian Trépo, Karsten Wursthorn and Patrick Marcellin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Scott Bowden

87 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy1 ☆

2004 733 citations Scott Bowden, George Lau et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott Bowden Australia	34	3.8k	3.5k	814	238	190	89	4.3k
Janice A. Kolberg United States	26	2.8k 0.7×	2.9k 0.8×	840 1.0×	644 2.7×	581 3.1×	63	4.3k
Stéphane Chevaliez France	35	2.9k 0.8×	2.9k 0.8×	831 1.0×	277 1.2×	119 0.6×	144	3.6k
Nico Lelie Netherlands	31	2.1k 0.6×	1.9k 0.5×	696 0.9×	191 0.8×	256 1.3×	54	2.7k
G Verme Italy	37	4.5k 1.2×	4.2k 1.2×	575 0.7×	335 1.4×	83 0.4×	136	5.6k
Sílvia Sauleda Spain	27	2.0k 0.5×	1.9k 0.5×	593 0.7×	499 2.1×	140 0.7×	83	3.7k
Etsuro Orito Japan	44	5.2k 1.4×	5.3k 1.5×	669 0.8×	473 2.0×	121 0.6×	137	6.4k
J W Shih United States	25	3.6k 0.9×	3.3k 0.9×	558 0.7×	401 1.7×	246 1.3×	40	4.6k
Luís F. López‐Cortés Spain	29	1.5k 0.4×	1.1k 0.3×	1.4k 1.7×	162 0.7×	631 3.3×	155	2.8k
M. S. Urdea United States	15	2.8k 0.7×	3.2k 0.9×	529 0.6×	358 1.5×	260 1.4×	18	3.7k
Huan Yan China	18	2.2k 0.6×	1.6k 0.5×	574 0.7×	543 2.3×	155 0.8×	46	2.9k

Countries citing papers authored by Scott Bowden

Since Specialization

Citations

This map shows the geographic impact of Scott Bowden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Bowden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Bowden more than expected).

Fields of papers citing papers by Scott Bowden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Bowden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Bowden. The network helps show where Scott Bowden may publish in the future.

Co-authorship network of co-authors of Scott Bowden

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Bowden. A scholar is included among the top collaborators of Scott Bowden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Bowden. Scott Bowden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pérez-Guaita, David, et al.. (2019). Spectroscopy goes viral: Diagnosis of hepatitis B and C virus infection from human sera using ATR-FTIR spectroscopy. SHILAP Revista de lepidopterología. 1. 100001–100001. 86 indexed citations

Jackson, Kathy Merlock, Jennifer H MacLachlan, Stephen Locarnini, et al.. (2018). Epidemiology and phylogenetic analysis of hepatitis D virus infection in Australia. Internal Medicine Journal. 48(11). 1308–1317. 8 indexed citations

Giles, Michelle, Kumar Visvanathan, Sharon R. Lewin, et al.. (2014). Clinical and virological predictors of hepatic flares in pregnant women with chronic hepatitis B. Gut. 64(11). 1810–1815. 84 indexed citations

Lim, Lucy, Scott J. Patterson, Jacob George, et al.. (2012). Tenofovir Rescue Therapy Achieves Long-Term Suppression of HBV Replication in Patients with Multi-Drug Resistant HBV: 4 Year Follow-Up of the TDF109 Cohort. Hepatology. 56. 3 indexed citations

Avihingsanon, Anchalee, Gail Matthews, Sharon R. Lewin, et al.. (2012). Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand. AIDS Research and Therapy. 9(1). 6–6. 25 indexed citations

Thompson, Alexander, Tin Nguyen, David Iser, et al.. (2010). Serum Hepatitis B Surface Antigen and Hepatitis B E Antigen Titers: Disease Phase Influences Correlation With Viral Load and Intrahepatic Hepatitis B Virus Markers. Hepatology. 51(6). 1933–1944. 354 indexed citations

Locarnini, Stephen & Scott Bowden. (2010). Drug Resistance in Antiviral Therapy. Clinics in Liver Disease. 14(3). 439–459. 22 indexed citations

Mohamadkhani, Ashraf, Masoud Sotoudeh, Scott Bowden, et al.. (2009). Downregulation of HLA Class II Molecules by G1896A Pre-Core Mutation in Chronic Hepatitis B Virus Infection. Viral Immunology. 22(5). 295–300. 8 indexed citations

Matthews, Gail, Eric C. Seaberg, Gregory J. Dore, et al.. (2009). Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals. AIDS. 23(13). 1707–1715. 42 indexed citations

10.

Eisen, Damon P., et al.. (2009). Decreased Viral Load and Symptoms of Polyomavirus‐Associated Chronic Interstitial Cystitis after Intravesical Cidofovir Treatment. Clinical Infectious Diseases. 48(9). e86–e88. 18 indexed citations

11.

Bayliss, Julianne, Ralf Moser, Scott Bowden, & Catriona McLean. (2009). Characterisation of single nucleotide polymorphisms in the genome of JC polyomavirus using MALDI TOF mass spectrometry. Journal of Virological Methods. 164(1-2). 63–67. 10 indexed citations

12.

Lewin, Sharon R., Ruy M. Ribeiro, Anchalee Avihingsanon, et al.. (2008). Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1–hepatitis B virus coinfected individuals: Similar effectiveness of lamivudine, tenofovir, or combination therapy #. Hepatology. 49(4). 1113–1121. 18 indexed citations

13.

Hui, Chee‐Kin, Scott Bowden, Haiying Zhang, et al.. (2006). Comparison of Real-Time PCR Assays for Monitoring Serum Hepatitis B Virus DNA Levels during Antiviral Therapy. Journal of Clinical Microbiology. 44(8). 2983–2987. 11 indexed citations

14.

Bowden, Scott. (2006). Serological and Molecular Diagnosis. Seminars in Liver Disease. 26(2). 97–103. 14 indexed citations

15.

Bowden, Scott, Kathy Merlock Jackson, Margaret Littlejohn, & Stephen Locarnini. (2004). Quantification of HBV Covalently Closed Circular DNA from Liver Tissue by Real-Time PCR. Humana Press eBooks. 95. 41–50. 35 indexed citations

16.

Lim, Wai H., et al.. (2003). Use of cidofovir in polyomavirus BK viral nephropathy in two renal allograft recipients. Nephrology. 8(6). 318–323. 26 indexed citations

17.

Hellard, Margaret, et al.. (2003). Investigation of infection control practices and knowledge of hepatitis C among body-piercing practitioners. American Journal of Infection Control. 31(4). 215–220. 15 indexed citations

18.

Hellard, Margaret, et al.. (2002). Hepatitis C Virus and Body Piercing. Environmental Health. 2(4). 79.

19.

Aye, Thein Thein, Angeline Bartholomeusz, Tim Shaw, et al.. (1997). Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation. Journal of Hepatology. 26(5). 1148–1153. 129 indexed citations

20.

Angus, Peter, Michael J. Richards, Scott Bowden, et al.. (1993). Combination antiviral therapy controls severe post‐liver transplant recurrence of hepatitis B virus infection. Journal of Gastroenterology and Hepatology. 8(4). 353–357. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact